The Times Tech Podcast
Age1’s Alex Colville: “Inventing the anti-ageing pill”
Oct 13, 2023
Alex Colville, co-founder of Age1, talks about funding longevity science, studying the biology of ageing, the rise of geroscience, healthspan, the potential of metformin, working on an anti-ageing treatment, and how long he thinks we'll live.
42:56
Episode guests
AI Summary
AI Chapters
Episode notes
Podcast summary created with Snipd AI
Quick takeaways
- The field of aging research is shifting towards treating aging as an affliction that can be treated, rather than solely focusing on age-related diseases.
- Geroprotectors, interventions that target the biological processes of aging, have the potential to significantly extend human lifespan and healthspan if further research and trials are conducted.
Deep dives
Investing in Longevity
Alex Colville, co-founder of the investment fund H1, discusses their mission to invest in startups focused on extending healthy life through aging interventions. They aim to support entrepreneurs in developing the 'magic pill' that can significantly extend human lifespan. With increasing attention and funding in the field, they believe that groundbreaking therapies for aging could be approved within the next decade.
Remember Everything You Learn from Podcasts
Save insights instantly, chat with episodes, and build lasting knowledge - all powered by AI.
